Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
4/3/2025 | $9.00 | Neutral | B. Riley Securities |
10/18/2024 | $11.75 | Buy | Berenberg |
9/19/2024 | $12.00 | Buy | Alliance Global Partners |
10/10/2022 | $9.00 | Outperform → Neutral | Robert W. Baird |
10/6/2022 | $13.00 → $9.00 | Outperform → Market Perform | BMO Capital Markets |
7/7/2022 | Mkt Perform | JMP Securities | |
1/13/2022 | Overweight → Sector Weight | Keybanc | |
9/20/2021 | $17.00 | Overweight | Keybanc |
4 - Global Medical REIT Inc. (0001533615) (Issuer)
4 - Global Medical REIT Inc. (0001533615) (Issuer)
4 - Global Medical REIT Inc. (0001533615) (Issuer)
8-K - Global Medical REIT Inc. (0001533615) (Filer)
SCHEDULE 13G - Global Medical REIT Inc. (0001533615) (Subject)
8-K - Global Medical REIT Inc. (0001533615) (Filer)
Chief Executive Officer Transition Expected in 2025 Mr. Busch to Remain on Board of Directors as Non-Executive Chairman Lori Wittman Appointed Lead Independent Director Effective January 1, 2025 Global Medical REIT Inc. (NYSE:GMRE) (the "Company" or "GMRE"), a net-lease medical real estate investment trust (REIT) that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems, today announced that as part of the Company's succession planning efforts, the Board of Directors (the "Board") has reached an agreement with Mr. Jeffrey Busch, Chairman of the Board of Directors and Chief Executive Officer ("CEO") of the Company,